Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: April 19, 2023 Report Code: GDME1520EPD-ST

Select Item

Thoracic Aortic Stent Grafts Pipeline Market Report Overview

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. The Thoracic Aortic Stent Grafts pipeline market research report provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thoracic Aortic Stent Grafts Pipeline Market Segmentation by Territories

Some of the key territories in the Thoracic Aortic Stent Grafts pipeline market are the US, China, Europe, Japan, and Canada. In 2023, the US has the highest number of pipeline products.

Thoracic Aortic Stent Grafts Pipeline Market Analysis, by Territories, 2023 (%)

Thoracic Aortic Stent Grafts Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the Thoracic Aortic Stent Grafts pipeline market, download a free report sample

Thoracic Aortic Stent Grafts Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the Thoracic Aortic Stent Grafts pipeline market are PMA, NMPA, Shonin, CE, and MDL. In 2023, PMA was the most followed regulatory path for pipeline products.

Thoracic Aortic Stent Grafts Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Thoracic Aortic Stent Grafts Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Thoracic Aortic Stent Grafts pipeline market, download a free report sample

Thoracic Aortic Stent Grafts Pipeline Market – Competitive Landscape

Some of the key companies in the Thoracic Aortic Stent Grafts pipeline market are APT Medical Inc, Artivion Inc, Beijing Tianzhu Ruichang Medical Technology Co Ltd, EndoSpan Ltd, Evasc Medical Systems Corp, Hangzhou Endonom Medtech Co Ltd, JOTEC GmbH, Lombard Medical Technologies Inc., Lundquist, and Medtronic Plc.

APT Medical Inc: Headquartered in Nanshan District, Shenzhen, China, APT Medical Inc is a supplier and manufacturer of EP and vascular intervention medical devices.

Artivion Inc: Headquartered in Atlanta, Georgia, the US, Artivion Inc (Artivion), formerly known as CryoLife Inc, is a medical device company that manufactures and distributes biosurgical devices and implantable human tissues for cardiac and vascular surgical procedures for the treatment of aortic disease. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, bovine pericardium, and mitral chordal repair products, photofix products and Jotec products. The company products serve physicians, cardiac surgeons, hospitals, and medical institutions.

Beijing Tianzhu Ruichang Medical Technology Co Ltd: Beijing Tianzhu Ruichang Medical Technology Co Ltd is a medical device company which focusses on the development and production of innovative aortic stent graft systems.

Thoracic Aortic Stent Grafts Pipeline Market Report Overview

Key Territories The US, China, Europe, Japan, and Canada
Key Regulatory Paths PMA, NMPA, Shonin, CE, and MDL
Leading Companies APT Medical Inc, Artivion Inc, Beijing Tianzhu Ruichang Medical Technology Co Ltd, EndoSpan Ltd, Evasc Medical Systems Corp, Hangzhou Endonom Medtech Co Ltd, JOTEC GmbH, Lombard Medical Technologies Inc., Lundquist, and Medtronic Plc.

Segments Covered in the Report

Thoracic Aortic Stent Grafts Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Japan
  • Canada

Thoracic Aortic Stent Grafts Pipeline Market Regulatory Paths Outlook

  • PMA
  • NMPA
  • Shonin
  • CE
  • MDL

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development.

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities.

  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects.

  • The coverage of pipeline products based on various stages of development ranging from early development to approved / issued stage.

  • The report provides key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to –

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.

  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development.

  • Develop market-entry and market expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

APT Medical Inc
Artivion Inc
Beijing Tianzhu Ruichang Medical Technology Co Ltd
EndoSpan Ltd
Evasc Medical Systems Corp
Hangzhou Endonom Medtech Co Ltd
JOTEC GmbH
Lombard Medical Technologies Inc.
Lundquist
Medtronic Plc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Terumo Aortic
TriVascular Inc
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Thoracic Aortic Stent Grafts Overview

  • 3 Products under Development

    • 3.1 Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development

    • 3.2 Thoracic Aortic Stent Grafts – Pipeline Products by Territory

    • 3.3 Thoracic Aortic Stent Grafts – Pipeline Products by Regulatory Path

    • 3.4 Thoracic Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

    • 3.5 Thoracic Aortic Stent Grafts – Ongoing Clinical Trials

  • 4 Thoracic Aortic Stent Grafts – Pipeline Products under Development by Companies

    • 4.1 Thoracic Aortic Stent Grafts Companies – Pipeline Products by Stage of Development

    • 4.2 Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development

  • 5 Thoracic Aortic Stent Grafts Companies and Product Overview

    • 5.1 APT Medical Inc Company Overview

      • 5.1.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Artivion Inc Company Overview

      • 5.2.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview

      • 5.3.1 Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 EndoSpan Ltd Company Overview

      • 5.4.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Evasc Medical Systems Corp Company Overview

      • 5.5.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Hangzhou Endonom Medtech Co Ltd Company Overview

      • 5.6.1 Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 JOTEC GmbH Company Overview

      • 5.7.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Lombard Medical Technologies Inc. Company Overview

      • 5.8.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Lundquist Company Overview

      • 5.9.1 Lundquist Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Medtronic Plc Company Overview

      • 5.10.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

      • 5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 St. Jude Medical LLC Company Overview

      • 5.12.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Terumo Aortic Company Overview

      • 5.13.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 TriVascular Inc Company Overview

      • 5.14.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

      • 5.15.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Thoracic Aortic Stent Grafts- Recent Developments

    • 6.1 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023

    • 6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company

    • 6.3 Feb 23, 2023: LeMaitre Q4 2022 Financial Results

    • 6.4 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023

    • 6.5 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president

    • 6.6 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer

    • 6.7 Nov 23, 2022: Medtronic Reports Quarterly Earnings

    • 6.8 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results

    • 6.9 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday

    • 6.10 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022

    • 6.11 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022

    • 6.12 Sep 07, 2022: Medtronic to appear at September investor conferences

    • 6.13 Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

    • 6.14 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results

    • 6.15 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results

    • 6.16 Jul 28, 2022: LeMaitre Q2 2022 Financial Results

    • 6.17 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022

    • 6.18 Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022

    • 6.19 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022

    • 6.20 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director

    • 6.21 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results

    • 6.22 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase

    • 6.23 Apr 28, 2022: LeMaitre Q1 2022 Financial Results

    • 6.24 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022

    • 6.25 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development 9

Thoracic Aortic Stent Grafts – Pipeline Products by Territory 10

Thoracic Aortic Stent Grafts – Pipeline Products by Regulatory Path 11

Thoracic Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 12

Thoracic Aortic Stent Grafts – Ongoing Clinical Trials 13

Thoracic Aortic Stent Grafts Companies – Pipeline Products by Stage of Development 14

Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development 15

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Thoracic Aortic Stent – Product Status 16

Thoracic Aortic Stent – Product Description 16

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Neo 2.0 – Product Status 17

Neo 2.0 – Product Description 17

Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Three-Branch Thoracic Aorta Stent Graft System – Product Status 18

Three-Branch Thoracic Aorta Stent Graft System – Product Description 18

EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Nexus – Product Status 19

Nexus – Product Description 19

EndoSpan Ltd – Ongoing Clinical Trials Overview 20

Nexus – A Multi-arm, Multi-center, Non-randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch 21

Nexus – A Non-Randomized, Prospective, Open-Label, Multi-Center, Observational Clinical Study to Further Evaluate Safety and Performance of the NEXUS Aortic Arch Stent Graft System 21

Nexus – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain” 21

Nexus – Feasibility Clinical Study to Evaluate the Safety and Performance of the NEXUS Aortic Arch Stent Graft System 22

Nexus – NEXUS Aortic Arch Stent Graft System Data Collection Study for Compassionate-Use Procedures 22

Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 23

TAS System – Product Status 23

TAS System – Product Description 23

Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

WeFlow-Tbranch Stent Graft System – Product Status 24

WeFlow-Tbranch Stent Graft System – Product Description 24

Hangzhou Endonom Medtech Co Ltd – Ongoing Clinical Trials Overview 25

WeFlow-Tbranch Stent Graft System – Guo’s Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: A Multicenter Pilot Study (Graft Study) 26

WeFlow-Tbranch Stent Graft System – Guo’s Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System (GUEST Study) 26

JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 27

E-nya Thoracic Stent Graft – Product Status 27

E-nya Thoracic Stent Graft – Product Description 27

E-Vita Open Neo – Product Status 28

E-Vita Open Neo – Product Description 28

JOTEC GmbH – Ongoing Clinical Trials Overview 29

E-nya Thoracic Stent Graft – CONFORM-TAA – A Post-market Clinical Follow-up Study in Patients with a Descending Thoracic Aortic Aneurysm or Penetrating Aortic Ulcer (PAU) Treated with the E-nya Thoracic Stent Graft System 30

E-nya Thoracic Stent Graft – CONFORM-TAD- A Post-market Clinical Follow-up Study in Patients with Complicated Acute, Subacute or Chronic Type B Aortic Dissection with Double Lumen Treated with the E-nya Thoracic Stent Graft System 30

E-Vita Open Neo – A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS 31

E-Vita Open Neo – NEO – E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections 31

E-Vita Open Neo – NEOS-APAC – Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO 31

Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

TEVAR – Product Status 32

TEVAR – Product Description 32

Lombard Medical Technologies Inc. – Ongoing Clinical Trials Overview 33

TEVAR – Scandinavian Trial of Uncomplicated Aortic Dissection Therapy 34

Lundquist Pipeline Products & Ongoing Clinical Trials Overview 35

Thoracic-Abdominal Endoluminal Graft – Product Status 35

Thoracic-Abdominal Endoluminal Graft – Product Description 35

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 36

Valiant Mona LSA System – Product Status 36

Valiant Mona LSA System – Product Description 36

Medtronic Plc – Ongoing Clinical Trials Overview 37

Valiant Mona LSA System – Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending Thoracic Aortic Aneurysms and Chronic Dissections 38

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 39

Aortic Stent Graft – Product Status 39

Aortic Stent Graft – Product Description 39

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 40

Amplatzer TAA Vascular Graft – Product Status 40

Amplatzer TAA Vascular Graft – Product Description 40

Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 41

RelayBranch Thoracic Stent-Graft System – Product Status 41

RelayBranch Thoracic Stent-Graft System – Product Description 41

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Status 42

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Description 42

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Status 43

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Description 43

Terumo Aortic – Ongoing Clinical Trials Overview 44

RelayBranch Thoracic Stent-Graft System – A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery 45

RelayBranch Thoracic Stent-Graft System – Cerebral Hemodynamics and Microemboli During Placement of RelayBranch Thoracic Stent-Graft System 45

RelayBranch Thoracic Stent-Graft System – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain” 45

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – A Prospective, Multi-center, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with an Acute, Complicated Type B Aortic Dissection 46

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Thoraflex Hybrid and Relay Extension Post-Approval Study 46

TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Ovation Thoracic Stent Graft System – Product Status 47

Ovation Thoracic Stent Graft System – Product Description 47

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Thoracic Aorta Stent Graft System – Product Status 48

Thoracic Aorta Stent Graft System – Product Description 49

Zylox-Tonbridge Medical Technology Co Ltd – Ongoing Clinical Trials Overview 50

Thoracic Aorta Stent Graft System – A Prospective, Multicenter, Objective Performance Criteria-controlled Study for National Medical Products Administration Approval of the Thoracic Aortic Stent Graft System 51

Glossary 76

Figures

Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development 9

Thoracic Aortic Stent Grafts – Pipeline Products by Territory 10

Thoracic Aortic Stent Grafts – Pipeline Products by Regulatory Path 11

Thoracic Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 12

Thoracic Aortic Stent Grafts – Ongoing Clinical Trials 13

Frequently asked questions

Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Thoracic Aortic Stent Grafts reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more